CTSH:NASDAQCognizant Technology Solutions Corporation Analysis
Data as of 2026-05-24 - not real-time
$52.75
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Cognizant is trading at $52.75, comfortably above its 20‑day SMA of 51.16 but still below the 50‑day SMA (56.66) and the 200‑day SMA (69.25), indicating short‑term momentum within a longer‑term bearish backdrop. The RSI sits at 49, suggesting neutral price pressure, while the MACD histogram is positive, giving a modest bullish signal despite a negative MACD line. Volatility remains elevated at 44% (30‑day), yet the stock’s beta of 0.64 points to lower systematic risk relative to the market. Valuation metrics are compelling: a trailing PE of 11.4x versus an industry average of 39.5x, and a DCF‑derived fair value of $68.20, implying roughly 37% upside.
Fundamentally, Cognizant delivers solid profitability with a 10.4% net margin, ROE near 15%, and a healthy cash position that exceeds its debt. The dividend yield of 2.5% is backed by a modest payout ratio of 27%, supporting sustainability. Recent corporate actions—doubling the 2026 buyback allocation to $2 billion and launching a $500 million accelerated share repurchase—signal confidence in cash generation. Additionally, the announced AI‑builder acquisition positions the firm to capture growth in high‑margin AI services.
Fundamentally, Cognizant delivers solid profitability with a 10.4% net margin, ROE near 15%, and a healthy cash position that exceeds its debt. The dividend yield of 2.5% is backed by a modest payout ratio of 27%, supporting sustainability. Recent corporate actions—doubling the 2026 buyback allocation to $2 billion and launching a $500 million accelerated share repurchase—signal confidence in cash generation. Additionally, the announced AI‑builder acquisition positions the firm to capture growth in high‑margin AI services.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Price near resistance at $56.23 with increasing volume
- Positive MACD histogram despite overall bearish trend
- Upcoming dividend ex‑date reinforcing cash return
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued valuation relative to industry and DCF fair value
- AI acquisition expanding high‑growth service offerings
- Robust share buyback program enhancing shareholder upside
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Sustainable dividend yield with low payout ratio
- Strong cash flow generation and net cash position
- Strategic positioning in AI and digital transformation markets
Key Metrics & Analysis
Financial Health
Revenue Growth5.80%
Profit Margin10.41%
P/E Ratio11.4
ROE14.88%
ROA10.44%
Debt/Equity7.25
P/B Ratio1.7
Op. Cash Flow$2.8B
Free Cash Flow$1.9B
Industry P/E39.5
Technical Analysis
TrendBearish
RSI49.1
Support$45.48
Resistance$56.23
MA 20$51.16
MA 50$56.66
MA 200$69.25
MACDBullish
VolumeIncreasing
Fear & Greed Index91.61
Valuation
Fair Value$68.20
Target Price$72.52
Upside/Downside37.48%
GradeUndervalued
TypeBlend
Dividend Yield2.50%
Risk Assessment
Beta0.64
Volatility44.15%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.